EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia

Xenia Kostoulias, Christina C Chang, Jessica Wisniewski, Iain J Abbott, Helen Zisis, Amanda Dennison, Denis W Spelman, Anton Y Peleg

Pathology · 2023

DOI: 10.1016/j.pathol.2023.03.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology, 2023. Verfasst von Xenia Kostoulias und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Prahran, Vic, Australia; Infection Program, Monash B…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Merck, Merck Sharp & Dohme (Australia) Pty Limited, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPseudomonas InfectionsAdultHumansPseudomonas aeruginosaMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialTazobactamCephalosporinsAnti-Bacterial AgentsAustralia

Stichwörter der Autor:innen

MDRP. aeruginosaXDRantimicrobial susceptibility testingceftolozane-tazobactamcystic fibrosis

Substanzen

ceftolozaneceftolozane, tazobactam drug combinationTazobactamCephalosporinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Prahran, Vic, Australia; Infection Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash Uni…
  • Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Prahran, Vic, Australia.
  • Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Prahran, Vic, Australia; Microbiology Unit, The Alfred Hospital, Prahran, Vic, Australia.
  • Microbiology Unit, The Alfred Hospital, Prahran, Vic, Australia.

Förderung

  • Merck
  • Merck Sharp & Dohme (Australia) Pty Limited
  • National Health and Medical Research Council

Zitieren

APA

Kostoulias, X., Chang, C. C., Wisniewski, J., Abbott, I. J., Zisis, H., Dennison, A., Spelman, D. W., & Peleg, A. Y. (2023). Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia. Pathology. https://doi.org/10.1016/j.pathol.2023.03.009

Vancouver

Kostoulias X, Chang CC, Wisniewski J, Abbott IJ, Zisis H, Dennison A, et al. Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia. Pathology. 2023. doi:10.1016/j.pathol.2023.03.009

BibTeX
@article{Kostoulias2023,
  author = {Kostoulias, Xenia and Chang, Christina C and Wisniewski, Jessica and Abbott, Iain J and Zisis, Helen and Dennison, Amanda and Spelman, Denis W and Peleg, Anton Y},
  title = {Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia},
  journal = {Pathology},
  year = {2023},
  doi = {10.1016/j.pathol.2023.03.009}
}
Kostenlos starten →